Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Knijff-Dutmer, E.A.J.
Right arrow Articles by Van de Laar, M.A.F.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knijff-Dutmer, E.A.J.
Right arrow Articles by Van de Laar, M.A.F.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2003; 96: 513-520
© 2003 Association of Physicians

The influence of cyclo-oxygenase specificity of non-steroidal anti-inflammatory drugs on bleeding complications in concomitant coumarine users

E.A.J. Knijff-Dutmer, J. Van der Palen, G. Schut and M.A.F.J. Van de Laar

From the Department of Rheumatology, Medisch Spectrum Twente, Enschede, The Netherlands

Received 12 February 2003 and in revised form 16 April 2003

Background: Concomitant use of coumarines and non-steroidal anti-inflammatory drugs (NSAIDs) may induce bleeding complications, due to the inhibition of both coagulant factors and platelet function. Unlike non-selective NSAIDs, cyclo-oxygenase-2 (COX-2)-selective NSAIDs interfere very little with platelet aggregation.

Aim: To determine whether COX-2-selective NSAIDs are associated with less bleeding complications in coumarine users, compared with non-selective NSAIDs.

Design: Prospective, nested case-control study.

Methods: We studied concomitant coumarine and NSAID users over two years. Patients with bleeding (cases), and frequency-matched patients without bleeding (controls), were sent questionnaires regarding possible risk factors for bleeding. International normalized ratio (INR) values were recorded. Univariate and multivariate analyses were used to detect factors contributing to bleeding.

Results: There were 1491 reported bleeds. NSAIDs were involved in 14.8%; 3.9% involving COX-2-selective NSAIDs. In non-bleeders, 2601 prescriptions with a coumarine/NSAID combination were detected; 9.7% were COX-2-selective. Adjusted ORs (95% CI) for a bleeding complication were 3.07 (1.18–8.03) for non-selective NSAID use, 3.01 (1.42–6.37) for NSAID use > 1 month, and 1.89 (1.03–3.49) for INR >= 4.0.

Discussion: In coumarine users, COX-2-selective NSAIDs are associated with less bleeding complications than non-selective NSAIDs are. Duration of NSAID use, as well as intensity of coumarine treatment, plays an important additional role. When the coumarine-NSAID combination is inevitable in an individual patient, a COX-2-selective NSAID may be preferred, with careful monitoring of the INR.

Address correspondence to Dr E.A.J. Knijff-Dutmer, Department of Rheumatology, Medisch Spectrum Twente, P.O. Box 50 000, 7500 KA Enschede, The Netherlands. e-mail: eajknijff{at}hotmail.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
N. A. Goldenberg, L. Jacobson, and M. J. Manco-Johnson
Brief Communication: Duration of Platelet Dysfunction after a 7-Day Course of Ibuprofen
Ann Intern Med, April 5, 2005; 142(7): 506 - 509.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Battistella, M. M. Mamdami, D. N. Juurlink, L. Rabeneck, and A. Laupacis
Risk of Upper Gastrointestinal Hemorrhage in Warfarin Users Treated With Nonselective NSAIDs or COX-2 Inhibitors
Arch Intern Med, January 24, 2005; 165(2): 189 - 192.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.